Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Charles River Laboratories International, Inc. Banner

Charles River Laboratories International, Inc.

CRL Stock Analysis

Page title

Section title

About Charles River Laboratories International, Inc.

Medical - Diagnostics & Research
Healthcare

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers...

Charles River Laboratories International, Inc. Key Metrics

Market Cap
$11B
52 Weeks Low
$161.65
52 Weeks High
$275
P/B
2.85x
P/E
24.61x
P/S
2.61x

Upcoming Events

    CRL Analyst Forecasts

    ‌
    ‌

    CRL Financials

    CRL Income Statement Key Metrics

    • Revenue(TTM)4.08 B
    • Gross Profit(TTM)1.38 B
    • EBITDA(TTM)1.03 B
    • Net Income(TTM)431.79 M
    • EPS Diluted(TTM)8.459999999999999

    Decode CRL's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    CRL earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of CRL (0.364) is lower than the average of its peers (0.465).

    Net Profit Margin vs Peers

    Net profit margin ratio of CRL (0.115) is higher than the average of its peers (-0.044).

    CRL Return on Equity

    See how efficiently CRL generates profit for it's shareholders.

    13.20%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of CRL (0.132) is higher than the average of its peers (-0.584).

    Return on Equity Growth

    CRL's Return on Equity has shown poor growth over the past 10 years, increasing by only -3.50%.

    CRL Revenue Growth

    See how CRL has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    CRL's revenue has grown significantly over the past 10 years, increasing by over 12.27%.